| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| D427158-1ml | 1ml | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $330.90 |
| Synonyms | 960404-48-2 | Dapagliflozin propanediol | dapagliflozin propanediol monohydrate | Dapagliflozin propanediol hydrate | Farxiga | Dapagliflozin ((2S)-1,2-propanediol, hydrate) | Dapagliflozin S-propylene glycol monohydrate | UNII-887K2391VH | CHEBI:85079 | BMS-512148-05 | Dapa |
|---|---|
| Specifications & Purity | 10mM in DMSO |
| Storage Temp | Store at -80°C |
| Shipped In | Ice chest + Ice pads |
| IUPAC Name | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2S)-propane-1,2-diol;hydrate |
|---|---|
| INCHI | InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1 |
| InChi Key | GOADIQFWSVMMRJ-UPGAGZFNSA-N |
| Canonical SMILES | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O |
| Isomeric SMILES | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl.C[C@@H](CO)O.O |
| Alternate CAS | 1700615-13-9,960404-48-2 |
| PubChem CID | 24906252 |
| Molecular Weight | 502.98 |
Enter Lot Number to search for COA:
| Pictogram(s) | GHS08, GHS09, GHS07 |
|---|---|
| Signal | Danger |
| Hazard Statements | H319:Causes serious eye irritation H373:Causes damage to organs through prolonged or repeated exposure H411:Toxic to aquatic life with long lasting effects H302:Harmful if swallowed H372:Causes damage to organs through prolonged or repeated exposure H360:May damage fertility or the unborn child H361:Suspected of damaging fertility or the unborn child H360D:May damage the unborn child H362:May cause harm to breast-fed children |
| Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P391:Collect spillage. P330:Rinse mouth. P263:Avoid contact during pregnancy/while nursing. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. P319:Get medical help if you feel unwell. |
| 1. Xueru He, Ying Li, Yinling Ma, Yuhao Fu, Xuejiao Xun, Yanjun Cui, Zhanjun Dong. (2022) Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats. MOLECULES, 27 (19): (6190). [PMID:36234746] [10.3390/molecules27196190] |
| 2. Qingyu Wang, Chen Wang, Shang Ma, Ping Lu, Jian Dong. (2018) Amphiphilic Optimization Enables Polyaspartamides with Effective Kinetic Inhibition of Tetrahydrofuran Hydrate Formation: Structure–Property Relationships. ACS Sustainable Chemistry & Engineering, 6 (10): (13532–13542). [PMID:] [10.1021/acssuschemeng.8b03615] |
| 1. Xueru He, Ying Li, Yinling Ma, Yuhao Fu, Xuejiao Xun, Yanjun Cui, Zhanjun Dong. (2022) Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats. MOLECULES, 27 (19): (6190). [PMID:36234746] [10.3390/molecules27196190] |
| 2. Qingyu Wang, Chen Wang, Shang Ma, Ping Lu, Jian Dong. (2018) Amphiphilic Optimization Enables Polyaspartamides with Effective Kinetic Inhibition of Tetrahydrofuran Hydrate Formation: Structure–Property Relationships. ACS Sustainable Chemistry & Engineering, 6 (10): (13532–13542). [PMID:] [10.1021/acssuschemeng.8b03615] |
